Beta-agonist stimulation ameliorates the phenotype of spinal and bulbar muscular atrophy mice and patient-derived myotubes

β 2 -Adrenoceptor agonists as novel, safe and potentially effective therapies for Amyotrophic lateral sclerosis (ALS)

(2016) Raymond T. Bartus et al.   NEUROBIOLOGY OF DISEASE

Serine phosphorylation and arginine methylation at the crossroads to neurodegeneration

(2015) Manuela Basso et al.   EXPERIMENTAL NEUROLOGY

Androgen-dependent loss of muscle BDNF mRNA in two mouse models of SBMA

(2015) Katherine Halievski et al.   EXPERIMENTAL NEUROLOGY

Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy

(2015) Kentaro Oki et al.   JOURNAL OF APPLIED PHYSIOLOGY

In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy

(2015) Maria Pennuto et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Fitting Linear Mixed-Effects Models Usinglme4

(2015) Douglas Bates et al.   Journal of Statistical Software

Protein Arginine Methyltransferase 6 Enhances Polyglutamine-Expanded Androgen Receptor Function and Toxicity in Spinal and Bulbar Muscular Atrophy

(2015) Chiara Scaramuzzino et al.   NEURON

Repurpose terbutaline sulfate for amyotrophic lateral sclerosis using electronic medical records

(2015) Hyojung Paik et al.   Scientific Reports

Brugada syndrome in spinal and bulbar muscular atrophy

(2014) A. Araki et al.   NEUROLOGY

Muscle Expression of Mutant Androgen Receptor Accounts for Systemic and Motor Neuron Disease Phenotypes in Spinal and Bulbar Muscular Atrophy

(2014) Constanza J. Cortes et al.   NEURON

Peripheral Androgen Receptor Gene Suppression Rescues Disease in Mouse Models of Spinal and Bulbar Muscular Atrophy

(2014) Andrew P. Lieberman et al.   Cell Reports

Androgen-dependent impairment of myogenesis in spinal and bulbar muscular atrophy

(2013) Adriana Malena et al.   ACTA NEUROPATHOLOGICA

Mechanisms regulating skeletal muscle growth and atrophy

(2013) Stefano Schiaffino et al.   FEBS Journal

β2-Adrenergic agonists and the treatment of skeletal muscle wasting disorders

(2013) Olivier R. Joassard et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

Unknown

(2013) Carlo Rinaldi et al.   MOLECULAR MEDICINE

Pilot trial of clenbuterol in spinal and bulbar muscular atrophy

(2013) G. Querin et al.   NEUROLOGY

Neurotoxic effects of androgens in spinal and bulbar muscular atrophy

(2011) Sara Parodi et al.   FRONTIERS IN NEUROENDOCRINOLOGY

Impaired motoneuronal retrograde transport in two models of SBMA implicates two sites of androgen action

(2011) Michael Q. Kemp et al.   HUMAN MOLECULAR GENETICS

Cell-autonomous and non-cell-autonomous toxicity in polyglutamine diseases

(2011) Fabio Sambataro et al.   PROGRESS IN NEUROBIOLOGY

Salbutamol increases survival motor neuron (SMN) transcript levels in leucocytes of spinal muscular atrophy (SMA) patients: relevance for clinical trial design

(2010) F. D. Tiziano et al.   JOURNAL OF MEDICAL GENETICS

Efficacy and safety of leuprorelin in patients with spinal and bulbar muscular atrophy (JASMITT study): a multicentre, randomised, double-blind, placebo-controlled trial

(2010) Masahisa Katsuno et al.   LANCET NEUROLOGY

Inducible activation of Akt increases skeletal muscle mass and force without satellite cell activation

(2009) Bert Blaauw et al.   FASEB JOURNAL

Overexpression of IGF-1 in Muscle Attenuates Disease in a Mouse Model of Spinal and Bulbar Muscular Atrophy

(2009) Isabella Palazzolo et al.   NEURON

Daily salbutamol in young patients with SMA type II

(2008) Marika Pane et al.   NEUROMUSCULAR DISORDERS

Role of β-Adrenoceptor Signaling in Skeletal Muscle: Implications for Muscle Wasting and Disease

(2008) Gordon S. Lynch et al.   PHYSIOLOGICAL REVIEWS